Use of NSAIDs and COVID19

19 March 2020 –

Over-the-counter (OTC) non-steroidal anti-inflammatory drugs (NSAIDs) in Australia have been approved by the Therapeutic Goods Administration to reduce fever and temporarily relieve aches and pains.

OTC NSAIDs, including ibuprofen, are well-established and rigorously tested medicines that have been used safely for decades, proving effective for the temporary relief of pain and fever.

Based on all available information, Consumer Healthcare Products (CHP) Australia is not aware of any scientific evidence supporting claims made in recent days suggesting that the use of NSAIDs, such as ibuprofen, could affect the health outcomes of COVID-19 patients.

That said, individuals diagnosed with COVID-19 should follow the advice provided by their healthcare professional.

This is consistent with updated NSAIDs medicines advice provided by the European Medicines Agency:

“There is currently no scientific evidence establishing a link between ibuprofen and worsening of COVID01119.”

“When starting treatment for fever or pain in COVID-19, patients and healthcare professionals should consider all available treatment options including paracetamol and NSAIDs.”

“There is currently no reason for patients taking ibuprofen to interrupt their treatment”

As always, before using any medicine consumers should read the label, follow the instructions for use (including any label warnings), and seek from advice their doctor or pharmacist if they have any concerns.

Media and Publications